The independent expert body tasked with making recommendations on whether new medications should receive government subsidies ...

Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...

Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines under the ...

Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

Background Health technology assessment (HTA) is a valuable tool for informing the efficient allocation of resources in ...

A tranche of cost of living measures will kick in today, with millions to see the change in their bank accounts within days.

Sky News contributor Clare Row has weighed in on a range of Labor's cost-of-living relief measures set to help struggling ...

Raipur: Chhattisgarh is positioning itself as a new pharmaceutical centre in central India, with the Naya Raipur Atal Nagar Development Authority allo.

In a new report, the ANAO deemed the Pharmaceutical Benefits Scheme, under which the PBAC operates, only “partly effective”, having consistently failed to meet performance requirements since 2022.

One of the world’s largest pharmaceutical companies will consider any opportunity to expand its operations in Australia, ...

Oddly enough, it was then she texted a friend, in almost a nervously joking manner, “wouldn’t it be funny if I had leukaemia ...